Back to Search
Start Over
The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson's and Huntington's Diseases.
- Source :
-
ACS chemical neuroscience [ACS Chem Neurosci] 2017 Nov 15; Vol. 8 (11), pp. 2356-2368. Date of Electronic Publication: 2017 Sep 15. - Publication Year :
- 2017
-
Abstract
- Among the diseases affecting the central nervous system (CNS), neurodegenerations attract the interest of both the clinician and the medicinal chemist. The increasing average age of population, the growing number of patients, and the lack of long-term effective remedies push ahead the quest for novel tools against this class of pathologies. We present a review on the state of the art of the molecules (or combination of molecules) of natural origin that are currently under study against two well-defined pathologies: Parkinson's disease (PD) and Huntington's disease (HD). Nowadays, very few tools are available for preventing or counteracting the progression of such diseases. Two major parameters were considered for the preparation of this review: particular attention was reserved to these research works presenting well-defined molecular mechanisms for the studied compounds, and where available, papers reporting in vivo data were preferred. A literature search for peer-reviewed articles using PubMed, Scopus, and Reaxys databases was performed, exploiting different keywords and logical operators: 91 papers were considered (preferentially published after 2015). The review presents a brief overview on the etiology of the studied neurodegenerations and the current treatments, followed by a detailed discussion of the natural and semisynthetic compounds dividing them in different paragraphs considering their several mechanisms of action.
- Subjects :
- Animals
Anti-Dyskinesia Agents chemical synthesis
Anti-Dyskinesia Agents economics
Anti-Dyskinesia Agents therapeutic use
Antioxidants pharmacology
Antioxidants therapeutic use
Antiparkinson Agents chemical synthesis
Antiparkinson Agents chemistry
Antiparkinson Agents economics
Antiparkinson Agents therapeutic use
Autophagy drug effects
Biological Products economics
Biological Products therapeutic use
Dementia drug therapy
Dementia economics
Dementia epidemiology
Dopamine metabolism
Drug Discovery
Drug Evaluation, Preclinical
Humans
Huntington Disease economics
Huntington Disease epidemiology
Huntington Disease physiopathology
Microglia drug effects
Mitochondria drug effects
Molecular Targeted Therapy
Monoamine Oxidase Inhibitors therapeutic use
Oxidative Stress drug effects
Parkinson Disease economics
Parkinson Disease epidemiology
Parkinson Disease physiopathology
Plant Preparations pharmacology
Plant Preparations therapeutic use
Protein Aggregation, Pathological drug therapy
Signal Transduction drug effects
alpha-Synuclein antagonists & inhibitors
Anti-Dyskinesia Agents chemistry
Biological Products chemistry
Huntington Disease drug therapy
Parkinson Disease drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1948-7193
- Volume :
- 8
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- ACS chemical neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 28862431
- Full Text :
- https://doi.org/10.1021/acschemneuro.7b00283